Literature DB >> 2042450

Heparin-associated thrombocytopenia in a patient with polycythemia vera: the importance of a marked drop in platelet count.

S Garcia1, A Cervero, M Sanchez, P Colomina.   

Abstract

The present report describes a patient with polycythemia vera who developed a severe arterial and venous thrombosis caused by systemically administered heparin. An immunologic implication has been proposed as pathophysiological mechanism of this heparin-associated thrombocytopenia and thrombosis syndrome. It is suggested, however, that a strong decrease in platelet count as occurred in this patient leads to a higher chance of developing this complication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042450     DOI: 10.1159/000204883

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Heparin-induced thrombocytopenia associated with polycythemia vera during the treatment of acute coronary syndrome.

Authors:  Takashi Yoshizane; Makoto Iwama; Takahiro Ueno; Maya Ishiguro; Yoshiaki Goto; Koji Ono; Masazumi Arai; Toshiyuki Noda
Journal:  J Cardiol Cases       Date:  2016-04-28

2.  [Heparin-induced thrombocytopenia with unfractionated heparin. A prospective study of inpatient treatment of internal medicine patients].

Authors:  H Heidrich; K Kahl; C Penninger; B Bechstein; M Birkenmaier; S Dressler; C Fahrig; J Helmis; G Herman; U von Knobloch; M Ladleif; K Meier; M Rudolph; B Schlich; M Wanke; B Zwernemann
Journal:  Med Klin (Munich)       Date:  1998-06-15

3.  Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Authors:  Sara C Meyer; Eva Steinmann; Thomas Lehmann; Patricia Muesser; Jakob R Passweg; Radek C Skoda; Dimitrios A Tsakiris
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.